-
NYU Dataset
Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients
- Alternate Title(s)
- CONTAIN COVID-19
- Authors
- Mila Brum OrtigozaHyunah YoonKeith GoldfeldGia F. Cobb2 more author(s)...
- Description
CONTAIN COVID-19 was a randomized, double-blinded, phase 2 controlled trial which examined the safety and efficacy of convalescent plasma versus a placebo (saline solution) to treat patients who were hospitalized with COVID-19. Inclusion criteria: Being at least 18 years of age Hospitalization with laboratory-confirmed COVID-19 At least one respiratory sign or symptom: cough, chest pain, shortness...
- Subject
-
COVID-19Health Care System
- Access Rights
- Application RequiredAuthor Approval Required